ESBATECH - A NOVARTIS COMPANY LLC has a total of 13 patent applications. Its first patent ever was published in 2009. It filed its patents most often in Republic of Korea, Hong Kong and Canada. Its main competitors in its focus markets pharmaceuticals, biotechnology and organic fine chemistry are ELSALYS BIOTECH, HELION BIOTECH APS and DUECKER KLAUS.
# | Country | Total Patents | |
---|---|---|---|
#1 | Republic of Korea | 7 | |
#2 | Hong Kong | 2 | |
#3 | Canada | 1 | |
#4 | EPO (European Patent Office) | 1 | |
#5 | United States | 1 | |
#6 | South Africa | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Organic fine chemistry | |
#4 | Measurement |
# | Technology | |
---|---|---|
#1 | Peptides | |
#2 | Medical preparations | |
#3 | Therapeutic chemical compounds | |
#4 | Sugars | |
#5 | Microorganisms | |
#6 | Analysing materials |
# | Name | Total Patents |
---|---|---|
#1 | Urech David | 10 |
#2 | Borras Leonardo | 9 |
#3 | Gunde Tea | 5 |
#4 | Escher Dominik | 3 |
#5 | Hulmann Cottier Valeerie | 1 |
Publication | Filing date | Title |
---|---|---|
US2016304627A1 | Acceptor framework for cdr grafting |